It's Complicated: FDA Prohibits CBD In Supplements, Enforcement Priority On Disease Claims
This article was originally published in The Rose Sheet
Executive Summary
As FDA announces its first-ever approval of a drug that contains a substance derived from marijuana, officials say the agency's policy that prohibits CBD's use in dietary supplements or food will not change. They also say, however, that FDA's priority for enforcement actions against dietary supplements containing CBD, an extract from cannabis and hemp plants, will remain on products marketed with drug or disease claims.